Related Experiment Video
Updated: Jun 5, 2026
07:27
The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury
Published on: October 21, 2017
CIDEB and CGI-58 differentially regulate liver lipid-droplet cholesterol to modulate metabolic dysfunction-associated
Ikki Sakuma1, Rafael C Gaspar2, Henrique N Morgan2
1Departments of Internal Medicine, Yale School of Medicine, New Haven, CT 06520, USA; Departments of Molecular Diagnosis, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.
Cell Reports
|June 3, 2026
Summary
Silencing CIDEB protein reduces liver fat and inflammation in metabolic dysfunction-associated steatohepatitis (MASH) by lowering lipid droplet cholesterol. Conversely, inhibiting CGI-58 worsens MASH, highlighting their opposing roles.
Area of Science:
- Hepatology
- Molecular Biology
- Biochemistry
Background:
- Metabolic dysfunction-associated steatohepatitis (MASH) is a growing cause of liver disease and mortality.
- Effective therapies for MASH are urgently needed, necessitating research into its underlying molecular mechanisms.
Purpose of the Study:
- To investigate the opposing roles of lipid droplet proteins CIDEB and CGI-58 in MASH pathogenesis.
- To determine the impact of these proteins on liver lipid metabolism, specifically cholesterol content within lipid droplets.
Main Methods:
- Utilized antisense oligonucleotides to silence CIDEB or CGI-58 in mouse models of MASH.
- Administered cholesterol or bempedoic acid (cholesterol-synthesis inhibitor) to assess their impact on MASH progression.
- Analyzed liver triglyceride and cholesterol levels, plasma transaminases, and histological markers of liver injury.
Main Results:
- CIDEB silencing reduced liver lipid droplet triglyceride and cholesterol, improved plasma transaminases, and decreased inflammatory markers.
- These protective effects of CIDEB knockdown were abolished by cholesterol supplementation.
- CGI-58 knockdown exacerbated MASH, increasing lipid accumulation; bempedoic acid reversed these detrimental effects.
- Dual silencing revealed that CGI-58 is essential for CIDEB's protective function.
Conclusions:
- Liver lipid droplet cholesterol is a key factor in MASH, modulated by CIDEB and CGI-58.
- CIDEB knockdown protects against MASH by promoting CGI-58-dependent lipolysis.
- Targeting CIDEB or modulating lipid droplet cholesterol presents a potential therapeutic strategy for MASH.
Related Concept Videos
01:25Lipid Catabolism
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...